Scarica l'app Stockscreener
0.4472
1.64%
0.0072
Dopo l'orario di chiusura:
.45
0.0028
+0.63%
Precedente Chiudi:
$0.44
Aprire:
$0.465
Volume 24 ore:
4.27M
Relative Volume:
13.02
Capitalizzazione di mercato:
$48.12M
Reddito:
$1.29M
Utile/perdita netta:
$-29.87M
Rapporto P/E:
-1.2422
EPS:
-0.36
Flusso di cassa netto:
$-14.70M
1 W Prestazione:
-25.47%
1M Prestazione:
-30.14%
6M Prestazione:
-10.56%
1 anno Prestazione:
-39.12%
Intervallo 1D:
$0.44
$0.5157
Intervallo di 1 settimana:
$0.43
$0.52
Portata 52W:
$0.3951
$0.94
VolitionRX Ltd Stock (VNRX) Company Profile
Nome
VolitionRX Ltd
Settore
Industria
Telefono
646 650 1351
Indirizzo
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
Confronta VNRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VNRX
VolitionRX Ltd
|
0.4472 | 49.57M | 1.29M | -29.87M | -14.70M | -0.36 |
|
TMO
Thermo Fisher Scientific Inc
|
536.78 | 198.56B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
210.92 | 147.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
637.34 | 50.96B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.10 | 39.13B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
205.75 | 34.81B | 15.70B | 1.24B | 2.01B | 6.9036 |
VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-08 | Iniziato | H.C. Wainwright | Buy |
| 2023-02-01 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-02-17 | Ripresa | Cantor Fitzgerald | Overweight |
| 2021-03-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-05-16 | Iniziato | Maxim Group | Buy |
| 2018-05-14 | Reiterato | The Benchmark Company | Buy |
| 2016-09-07 | Reiterato | Rodman & Renshaw | Buy |
| 2016-02-01 | Iniziato | Rodman & Renshaw | Buy |
Mostra tutto
VolitionRX Ltd Borsa (VNRX) Ultime notizie
Volitionrx (VNRX) president Reynolds buys $56,100 in shares By Investing.com - Investing.com South Africa
Still buys VolitionRx (VNRX) shares and warrants for $24,518 By Investing.com - Investing.com South Africa
Still buys VolitionRx (VNRX) shares and warrants for $24,518 - Investing.com
Volitionrx (VNRX) president Reynolds buys $56,100 in shares - Investing.com India
Volitionrx director Innes buys $49k in shares - Investing.com India
Using fundamentals and technicals on VolitionRx LimitedWeekly Gains Summary & Technical Entry and Exit Tips - newser.com
Does VolitionRx Limited show high probability of rebound2025 Growth vs Value & Long-Term Growth Plans - newser.com
Can VolitionRX Limited stock sustain free cash flowGDP Growth & Safe Capital Growth Plans - newser.com
Published on: 2025-10-13 09:58:07 - newser.com
Published on: 2025-10-13 06:57:47 - newser.com
VolitionRx prices $6 million public offering of common stock and warrants By Investing.com - Investing.com South Africa
VolitionRx prices $6 million public offering of common stock and warrants - Investing.com India
VolitionRx (VNRX) Sets Pricing for Public Offering of Shares and Warrants - GuruFocus
VolitionRx Prices Public Offering Of 11.55 Mln Shares And Warrants At $0.52/set; Shares Fall - Nasdaq
$6.0M Gross Proceeds — VolitionRx Prices 11.55M Shares & Warrants; Close Expected Oct 14, 2025 - Stock Titan
Levi Strauss, USANA Health Sciences And 3 Stocks To Watch Heading Into Friday - Benzinga
VolitionRx (VNRX) Plans Public Offering to Bolster Development a - GuruFocus
Volitionrx stock tumbles on proposed public offering By Investing.com - Investing.com Nigeria
VolitionRx announces proposed public offering of common stock By Investing.com - Investing.com Australia
Volitionrx stock tumbles on proposed public offering - Investing.com India
VolitionRx announces offering of common stock and warrants, no amount given - TipRanks
15% Overallotment Option: VolitionRx Proposes Underwritten Offering of Common Stock & Warrants - Stock Titan
Live market analysis of VolitionRx LimitedJuly 2025 Decliners & Expert Verified Stock Movement Alerts - newser.com
VolitionRx Limited Stock Analysis and ForecastPrice Momentum Alerts & Build Diversified Portfolios With Ease - earlytimes.in
Is VolitionRx Limited a candidate for recovery playFed Meeting & Reliable Price Action Trade Plans - newser.com
Will a bounce in VolitionRx Limited offer an exit2025 Macro Impact & Real-Time Volume Analysis - newser.com
Is VolitionRX Limited stock resilient in recession scenariosJuly 2025 Setups & Weekly High Return Forecasts - newser.com
Will VolitionRX Limited stock boost dividends furtherNew Guidance & Accurate Buy Signal Notifications - newser.com
Beyond the Genome: Volition Showcases Revolutionary Nu.Q Platform for Epigenetic Drug Discovery - Stock Titan
VolitionRX (NYSEAMERICAN:VNRX) Trading 9% HigherShould You Buy? - MarketBeat
H.C. Wainwright reiterates buy rating on VolitionRX stock at $2.50 By Investing.com - Investing.com Australia
VolitionRX (VNRX) Receives Reiterated Buy Rating by HC Wainwrigh - GuruFocus
Why analysts remain bullish on VolitionRx Limited stockQuarterly Trade Report & Safe Entry Zone Tips - newser.com
VolitionRx Partners with Hologic to Expand Access to Epigenetic Testing Services for Drug Developers - citybuzz
VNRX Stock: Analyst Maintains 'Buy' Rating with $5.00 Price Targ - GuruFocus
What indicators show strength in VolitionRx Limited2025 Volume Leaders & Verified Entry Point Signals - newser.com
$200M Market Opportunity: Volition Teams with $4B Healthcare Giant Hologic for Epigenetic Testing Service - Stock Titan
What drives VolitionRx Limited stock priceEx-Dividend Date Alerts & Free Popular Stock Picks Selection - earlytimes.in
Institutional scanner results for VolitionRx LimitedGlobal Markets & Accurate Trade Setup Notifications - newser.com
News impact scoring models applied to VolitionRx LimitedJuly 2025 Summary & Expert Approved Trade Ideas - newser.com
Understanding VolitionRx Limited’s price movementWeekly Trade Analysis & Reliable Trade Execution Plans - newser.com
Using Python tools to backtest VolitionRx Limited strategiesMarket Trend Report & Weekly High Conviction Trade Ideas - newser.com
Real time pattern detection on VolitionRx Limited stock2025 Risk Factors & Free Safe Entry Trade Signal Reports - newser.com
VolitionRX Limited (NYSEAMERICAN:VNRX) Sees Large Growth in Short Interest - MarketBeat
How to monitor VolitionRx Limited with trend dashboardsIndex Update & Precise Buy Zone Tips - newser.com
VolitionRX Ltd Azioni (VNRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
VolitionRX Ltd Azioni (VNRX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Innes Guy Archibald | Director |
Oct 14 '25 |
Buy |
0.51 |
96,153 |
49,038 |
1,062,967 |
| STILL TIMOTHY I | Director |
Oct 14 '25 |
Buy |
0.51 |
48,076 |
24,519 |
1,535,458 |
| Reynolds Cameron John | President and CEO |
Sep 12 '25 |
Buy |
0.66 |
15,000 |
9,885 |
2,624,847 |
| Innes Guy Archibald | Director |
Aug 05 '25 |
Buy |
0.64 |
78,125 |
50,000 |
966,814 |
| Reynolds Cameron John | President and CEO |
Aug 05 '25 |
Buy |
0.64 |
78,125 |
50,000 |
2,609,847 |
| Reynolds Cameron John | President and CEO |
Jun 12 '25 |
Buy |
0.59 |
12,500 |
7,372 |
2,331,722 |
| Innes Guy Archibald | Director |
Jun 03 '25 |
Buy |
0.54 |
20,000 |
10,772 |
888,689 |
| Micallef Jacob Vincent | Chief Scientific Officer |
May 19 '25 |
Buy |
0.43 |
50,000 |
21,500 |
426,033 |
| Reynolds Cameron John | President and CEO |
May 19 '25 |
Buy |
0.44 |
20,000 |
8,730 |
2,319,222 |
| Reynolds Cameron John | President and CEO |
Mar 26 '25 |
Buy |
0.55 |
181,818 |
100,000 |
2,299,222 |
0.74%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):